Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tolnaftate 1% liquid spray
1310020Y0AAAPAP
|
Tolnaftate | Tolnaftate | Skin | 38 |
|
Scholl Athlete's Foot liquid spray
1310020Y0BEAFAP
|
Scholl (Athletes Foot) | Tolnaftate | Skin | 8 |
|
Tolnaftate 1% powder
1310020Y0AAABAB
|
Tolnaftate | Tolnaftate | Skin | 1 |
|
Dual Action Athlete's Foot 0.12% spray
1310020Y0BGAAAK
|
Boots Dual Action Athlete's Foot | Tolnaftate | Skin | No data available |
|
Dual Action Athlete's Foot cream
1310020Y0BGABAL
|
Boots Dual Action Athlete's Foot | Tolnaftate | Skin | No data available |
|
Dual Action Athlete's Foot powder
1310020Y0BGACAH
|
Boots Dual Action Athlete's Foot | Tolnaftate | Skin | No data available |
|
Mycil Athlete's Foot 1% spray
1310020Y0BFADAJ
|
Mycil | Tolnaftate | Skin | No data available |
|
Mycil ointment
1310020Y0BFABAG
|
Mycil | Tolnaftate | Skin | No data available |
|
Mycil powder
1310020Y0BFACAH
|
Mycil | Tolnaftate | Skin | No data available |
|
Scholl Athlete's Foot 1% cream
1310020Y0BEAAAA
|
Scholl (Athletes Foot) | Tolnaftate | Skin | No data available |
|
Scholl Athlete's Foot 1% powder
1310020Y0BEAEAB
|
Scholl (Athletes Foot) | Tolnaftate | Skin | No data available |
|
Tinaderm 1% cream
1310020Y0BBAAAA
|
Tinaderm | Tolnaftate | Skin | No data available |
|
Tinaderm Plus 1% powder
1310020Y0BBAEAB
|
Tinaderm | Tolnaftate | Skin | No data available |
|
Tolnaftate 0.12% spray
1310020Y0AAAKAK
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% / Benzalkonium chloride 0.1% cream
1310020Y0AAALAL
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% / Benzalkonium chloride 0.1% ointment
1310020Y0AAAGAG
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% / Chlorhexidine 0.25% powder
1310020Y0AAAHAH
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% cream
1310020Y0AAAAAA
|
Tolnaftate | Tolnaftate | Skin | No data available |
|
Tolnaftate 1% dry powder spray
1310020Y0AAAJAJ
|
Tolnaftate | Tolnaftate | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.